, and single breath transfer factor for carbon monoxide (TLCO) were within normal limits, and no difference was found between the groups. The combined data for both groups showed that smoking was highly associated with impairment in TLCO (P = 0.005), and smoking frequency was negatively correlated to TLCO (P = 0.002). We conclude that 3-4 courses with bleomycin, cisplatin and etoposide/vinblastine in testicular cancer patients do not lead to long-term impairment of pulmonary function.
The outlook for patients with metastatic germ cell testicular cancer was dramatically improved by the introduction of cisplatin (Einhorn & Donohue, 1977) . A 12-year survival of 65% in disseminated disease has been reported with combination chemotherapy based on cisplatin (Roth et al., 1988) , and a 5-year survival of 80% has been achieved with the present third generation regimens (Einhorn, 1987) . In stage II with disease confined to the testis and abdominal glands a cure rate as high as 98% has been achieved (Peckham, 1988) . The excellent treatment results have drawn attention to longterm toxic effects of cancer chemotherapy (Hansen et al., 1989; Gietema et al., 1992; Osanto et al., 1992; Craig et al., 1992) .
During the last 15 years cisplatin has been combined with bleomycin in routine chemotherapy of germ cell cancer. The most important toxic effects of bleomycin and cisplatin are pulmonary fibrosis and renal tubular disorder, respectively. The combination of the two drugs may increase the risk of bleomycin-induced pneumonitis because renal insufficiency induced by cisplatin reduces the urinary clearance of bleomycin (van Barneveld et al., 1984) . In view of the growing experience with long-term survivors, we have studied the pulmonary function in patients with germ cell testicular cancer 6-12 years after chemotherapy based on bleomycin and cisplatin.
Patients and methods

Patients
Retroperitoneal lymph node dissection (RPLND) was carried out in 141 patients with non-seminomatous testicular cancer clinical stage (cs) I and IIA at our institution during the years 1979-1986. Staging was performed according to the Royal Marsden Classification (Peckham et al., 1979 
Clinical variabtes
The medical records of each patient were reviewed with special attention to perioperative care, chemotherapy compliance, pulmonary symptoms, and chest X-rays. According to our routine chest X-rays were taken before each treatment course and four weeks after completed therapy. Chest X-ray changes which appeared during chemotherapy or the following month were judged as pulmonary toxicity if no other explanation was found. At long-term follow-up all patients went through clinical examination, chest X-ray and routine blood tests.
In addition the patients completed a self-administered questionnaire regarding physical condition, smoking habits, neurovascular symptoms and intercurrent disease. The patients were stratified as smokers and non-smokers. The smoking frequency and daily cigarette consumption were registered. (Ogilvie et al., 1957) and carried out according to the recommended guidelines (Cotes, 1983) . No correction for hemoglobin was done. All pulmonary function values were expressed as percentage of predicted value. Reference values were those of the European Community for Coal and Steel (ECCS) (Quanjer et al., 1983) .
Statistics
The necessary sample sizes for statistical comparison of the control and case group were calculated according to Pocock's equation (Pocock, 1983, pp. (Table II) , and by administrative errors in three patients. None of the patients developed pulmonary symptoms during chemotherapy, although pleural thickening and subpleural fibrosis emerged on chest X-rays in four At long-term follow-up the patient characteristics of the two groups were similar with respect to present drug treatment, history of cardiopulmonary disease, general anesthesia during follow-up, and airway infection during the last six weeks before testing (Table III) . Level of physical exercise and number of smokers were the same in the two groups (Table III) . There was no difference in daily cigarette consumption between smokers in the case (median 15, range 1-20) and the control (median 15, range 2-25) groups. The pulmonary function was within the normal range without significant differences between the groups (Table IV) . None of the patients had anemia, and there was no significant correlation between TLCO% and hemoglobin (correlation coefficient = 0.071) by linear regression analysis.
We found no association between smoking and the test results of FVC and FEV 1. On the other hand, the median In an extended retrospective overview of bleomycin 4d sustained Raynaud-like symptoms (P = 0.009).
monotherapy the incidence of drug-induced pneumonitis was chest X-ray densities seen during treatment had shown to be 3-7% (Lehne & Lote, 1990) . However, in a d in two patients while sustained fibrosis was seen in prospective study of combination chemotherapy in advanced her two at follow-up. Crackles on inspiration were germ cell malignancy, pulmonary toxicity has been reported at auscultation in one of these patients. The combined in as many as 46% of the patients (Levi et al., 1988 ed. This reflects a profound motivation for follow-up at least one year after discontinuation of the drug treatment nd a high degree of compliance among patients cured (Goldiner & Schweizer, 1979) . Long duration of anesthesia testicular cancer. Due to fulfillment of statistical and high inspiratory oxygen fraction increase the complicaments entry was stopped after 57 patients in each tion risk (Lehne & Lote, 1990) . However, the vulnerability By random selection 14 patients were excluded from does not increase if the preoperative pulmonary function is dy, eleven in ps II and three in ps I. According to the within normal limits (Lamantia et al., 1984 
